Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $23.01 million. The enterprise value is -$75.30 million.

Market Cap	23.01M
Enterprise Value	-75.30M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

TENX has 3.41 million shares outstanding. The number of shares has increased by 3,389.71% in one year.

Current Share Class	3.41M
Shares Outstanding	3.41M
Shares Change (YoY)	+3,389.71%
Shares Change (QoQ)	+980.62%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	24.67%
Float	2.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.24
P/TBV Ratio	0.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.95

Current Ratio	38.95
Quick Ratio	38.38
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-606.59

Financial Efficiency

Return on equity (ROE) is -26.84% and return on invested capital (ROIC) is -17.87%.

Return on Equity (ROE)	-26.84%
Return on Assets (ROA)	-17.39%
Return on Invested Capital (ROIC)	-17.87%
Return on Capital Employed (ROCE)	-15.98%
Revenue Per Employee	n/a
Profits Per Employee	-$2.43M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.17% in the last 52 weeks. The beta is 2.13, so TENX's price volatility has been higher than the market average.

Beta (5Y)	2.13
52-Week Price Change	+69.17%
50-Day Moving Average	6.34
200-Day Moving Average	4.47
Relative Strength Index (RSI)	51.52
Average Volume (20 Days)	53,856

Short Selling Information

The latest short interest is 217,185, so 6.37% of the outstanding shares have been sold short.

Short Interest	217,185
Short Previous Month	222,915
Short % of Shares Out	6.37%
Short % of Float	9.48%
Short Ratio (days to cover)	7.73

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.54M
Pretax Income	-10.10M
Net Income	-14.56M
EBITDA	-15.53M
EBIT	-15.54M
Earnings Per Share (EPS)	-$2.32

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	98.31M
Total Debt	n/a
Net Cash	98.31M
Net Cash Per Share	$28.84
Equity (Book Value)	97.22M
Book Value Per Share	28.52
Working Capital	97.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.46M
Capital Expenditures	n/a
Free Cash Flow	-12.46M
FCF Per Share	-$3.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,389.71%
Shareholder Yield	-3,389.71%
Earnings Yield	-63.28%
FCF Yield	-54.14%

Analyst Forecast

The average price target for TENX is $16.00, which is 206.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	206.22%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 0.0125:1.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	0.0125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2